Archive · 13 Aug 2025
Granules India Q1 FY26: Profit Down, Revenue Up
Granules India, a company that makes medicine ingredients, made less profit this past quarter, about 16% less.
However, the company made more money overall, about 3% more than last year.
They also had a lot of cash, around ₹280 crore, from their business activities.
The company passed some important inspections at its factories, and one of their factories got certified.
They are planning to keep growing in the future.
Granules India's net profit for Q1 FY26 decreased by 16% to ₹112 crore.
The company's total revenue increased by 3% to ₹1210 crore.
Healthy cash flow from operations reached ₹280.6 crore this quarter.
Successful USFDA audits were completed at multiple facilities.
The EU GMP inspection of Gagillapur concluded with certification.
- Who
- Granules India, led by Krishna Prasad Chigurupati.
- What
- Granules India's financial performance in Q1 FY26.
- When
- Q1 FY26, published August 12, 2025.
- Where
- Hyderabad, with operations at facilities like Bonthapally and Gagillapur.
- Why
- To understand the company's financial health and growth trajectory.
- Net Profit (Q1 FY26)
- ₹112 crore
- Net Profit Change
- -16%
- Total Revenue
- ₹1210 crore
- Revenue Change
- +3%
- Cash Flow from Operations
- ₹280.6 crore
- Company Location
- Hyderabad